Zucero Therapeutics is committed to the discovery and development of modified sugar compounds for the treatment of cancer and inflammatory conditions.

Zucero’s first clinical candidate is called pixatimod and enhances the ability of the immune system to recognise and destroy cancer.

 
checkpoint-inhibitors.jpg

IMMUNOTHERAPY

Immunotherapy is a type of cancer treatment that helps your immune system fight cancer.

bottles.jpg

OUR TECHNOLOGY

Read more about our first-in-class immunomodulatory agent pixatimod.

dr-holding-patient-hand.jpg

CLINICAL TRIALS

Learn more about our clinical trials and see if you are eligible to enrol.


LATEST NEWS AND UPDATES


LATEST PUBLICATIONS